NCT00704158View on ClinicalTrials.gov

Study of CR011-vcMMAE to Treat Locally Advanced or Metastatic Breast Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

November 30, 2010

Study Completion Date

June 30, 2011

Conditions
Breast Cancer
Interventions
DRUG

CR011-vcMMAE

administered as an intravenous infusion on Day 1 of a 21 day cycle.

Trial Locations (5)

10065

Cornell University, New York

30341

Georgia Cancer Specialists, Atlanta

33461

Hematology Oncology Associates, Lake Worth

33916

Florida Cancer Specialists, Fort Myers

37203

Tennessee Oncology, Nashville

Sponsors
All Listed Sponsors
lead

CuraGen Corporation

INDUSTRY

NCT00704158 - Study of CR011-vcMMAE to Treat Locally Advanced or Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter